Smart Money Is Betting Big In MRNA Options
Smart Money Is Betting Big In MRNA Options
Financial giants have made a conspicuous bullish move on Moderna. Our analysis of options history for Moderna (NASDAQ:MRNA) revealed 10 unusual trades.
金融巨頭們對moderna採取了顯眼的看好操作。我們對moderna（納斯達克股票代碼:mrna）期權歷史進行分析，發現有10筆不尋常的交易。
Delving into the details, we found 70% of traders were bullish, while 30% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $786,245, and 3 were calls, valued at $262,628.
深入研究發現，70%的交易者看好，而30%的交易者呈現看淡的趨勢。我們發現所有交易中有7筆看跌期權，總價值爲786,245美元，有3筆看漲期權，總價值爲262,628美元。
What's The Price Target?
價格目標是什麼？
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $220.0 for Moderna, spanning the last three months.
經過對成交量和持倉量的評估，現在明顯的是，主要的市場擁有者正關注moderna在一定價格區間內的表現，該區間涵蓋了過去三個月的時間，區間範圍爲100.0到220.0美元。
Analyzing Volume & Open Interest
分析成交量和未平倉合約
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
這些數據可以幫助您跟蹤Coinbase Glb期權的流動性和利益，以給定的行權價格爲基礎。
This data can help you track the liquidity and interest for Moderna's options for a given strike price.
此數據可以幫助您跟蹤moderna在給定行權價下期權的流動性和興趣。
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Moderna's whale activity within a strike price range from $100.0 to $220.0 in the last 30 days.
下面，我們可以觀察一下moderna所有鯨魚活動中，以100.0到220.0美元的行權價格範圍內的看漲和看跌期權交易量和持倉量的演變情況，以及過去30天內的概況。
Moderna Call and Put Volume: 30-Day Overview
Moderna看漲和看跌期權成交量：30天概況
Biggest Options Spotted:
最大的期權交易：
| Symbol | PUT/CALL | Trade Type | Sentiment | Exp. Date | Ask | Bid | Price | Strike Price | Total Trade Price | Open Interest | Volume |
|---|---|---|---|---|---|---|---|---|---|---|---|
| MRNA | PUT | TRADE | BULLISH | 10/18/24 | $17.1 | $16.75 | $16.75 | $150.00 | $502.5K | 751 | 1 |
| MRNA | CALL | SWEEP | BEARISH | 01/17/25 | $19.95 | $19.65 | $19.65 | $165.00 | $172.9K | 555 | 60 |
| MRNA | PUT | SWEEP | BULLISH | 01/17/25 | $25.15 | $24.95 | $24.95 | $155.00 | $129.7K | 220 | 99 |
| MRNA | CALL | SWEEP | BULLISH | 06/21/24 | $7.2 | $6.55 | $6.8 | $145.00 | $61.2K | 1.6K | 94 |
| MRNA | PUT | TRADE | BEARISH | 06/20/25 | $69.2 | $64.8 | $69.2 | $210.00 | $34.6K | 0 | 0 |
| 標的 | 看跌/看漲 | 交易類型 | 情緒 | 到期日 | 賣盤 | 買盤 | 價格 | 執行價格 | 總交易價格 | 未平倉合約數量 | 成交量 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Moderna | 看跌 | 交易 | 看好 | 10/18/24 | $17.1 | $16.75 | $16.75 | $150.00 | $502.5K | 751 | 1 |
| Moderna | 看漲 | SWEEP | 看淡 | 01/17/25 | $19.95 | $19.65 | $19.65 | 165.00美元 | $172.9K | 555 | 60 |
| Moderna | 看跌 | SWEEP | 看好 | 01/17/25 | $25.15 | $24.95 | $24.95 | $155.00 | $129.7K | 220 | 99 |
| Moderna | 看漲 | SWEEP | 看好 | 06/21/24 | $7.2 | $ 6.55 | $6.8 | $145.00 | $61.2K | 1.6K | 94 |
| Moderna | 看跌 | 交易 | 看淡 | 06/20/25 | $69.2 | $64.8 | $69.2 | 目標股價爲$210.00。 | $34.6K | 0 | 0 |
About Moderna
關於現代
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
Moderna是一家成立於2010年並於2018年12月進行首次公開發行的商業化生物技術公司。該公司的mRNA技術得到了驗證，其COVID-19疫苗在2020年12月獲得美國授權。截至2023年中期，Moderna共有39個mRNA開發候選藥物處於臨床試驗中。這些項目涉及多個治療領域，包括傳染病、腫瘤、心血管疾病和罕見遺傳疾病。
After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
在對Moderna周邊的期權交易進行全面評估後，我們進一步研究了公司的詳細情況，包括對其現有市場狀態和業績的評估。
Current Position of Moderna
Moderna現有狀態
- With a trading volume of 983,577, the price of MRNA is down by -0.39%, reaching $148.0.
- Current RSI values indicate that the stock is may be approaching overbought.
- Next earnings report is scheduled for 51 days from now.
- 成交量爲983,577，MRNA的價格下跌了-0.39%，達到148.0美元。
- 當前RSI值表明該股票可能接近超買狀態。
- 下一個季度收益報告將在51天后發佈。
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
期權與僅交易股票相比是一種更具風險的資產，但它們具有更高的利潤潛力。認真的期權交易者通過每日學習，進出交易，跟隨多個指標並密切關注市場來管理這種風險。
譯文內容由第三人軟體翻譯。